The British Medical Journal argues that evidence and ethics should inform policies that promote health and respect dignity, issue-areas which doctors and their leaders should champion.
The Guide applies a gender perspective to drug policy for Colombia, exploring the differentiated impact of imprisonment and suggesting recommendations for change.
EHRN describes the implementation of its 2014–2015 "Small Grants Program Through Peers’ Effort" in nine countries of Central and Eastern Europe and Central Asia.
The Tide Effect argues that cannabis legalisation and regulation is now inevitable and that the market-based approaches being developed in North America are the way forward.
The GCDP outline the failures of prohibition, the benefits of well-regulated decriminalisation, alternatives to incarceration and how to introduce regulated drug markets.
This report is not issued simply because of the prevalence of substance misuse or even the related devastating harms and costs, but also to help inform policymakers, health care professionals, and the general public about effective, practical, and sustainable strategies to address these problems.
HRI release their biennial report, discussing drug-related HIV, viral hepatitis and tuberculosis. It also integrates updated information on harm reduction services, including on needle and syringe programmes and opioid substitution therapy.
Public Health England have released a November 2016 update to their assessment of rates of, amongst others, HIV, hepatitis B and C in people who inject drugs in the UK.
As NPS have entered the markets at an unprecedented rate, legislation has been unable to keep pace. This report for policymakers and legal practioners, from the EMCDDA and Eurojust, aims to outline the challenges and paths forward in NPS regulation.
Prison reform under the MAS government confronts serious hurdles but has demonstrated a commitment to confront institutional problems in the judiciary, police, and prison systems through varied initiatives.
